Astrazeneca are now using CtDna analysis to guide treatment options during their drug trials. Angle's "dual analysis” is better. It is the "normal" CtDna analysis plus circulating tumour cell ...

Angle Plc. So EsoBiotec can program cells, & Parsortix can catch live22 May 2025 08:10 Cancerous cells. Makes one wonder if they will be able to do something with them or see what needs to be changed.

Here's the math behind the analysis and whether the company can hit these targets by the end of the decade. Video streaming processed through the cloud has turned the media sector into a truly ...